A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease
Authors
Keywords
-
Journal
ACTA NEUROPATHOLOGICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-15
DOI
10.1007/s00401-020-02249-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
- (2020) Simon Dujardin et al. NATURE MEDICINE
- Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients
- (2020) Felix Dinkel et al. Frontiers in Aging Neuroscience
- Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease
- (2020) Hendrik Wesseling et al. CELL
- Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
- (2019) Joseph F. Arboleda-Velasquez et al. NATURE MEDICINE
- Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease
- (2018) Yakeel T. Quiroz et al. JAMA Neurology
- Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
- (2018) Sarah L. DeVos et al. Frontiers in Neuroscience
- Phenotypic Profile of Early-Onset Familial Alzheimer's Disease Caused by Presenilin-1 E280A Mutation
- (2018) Diego Sepulveda-Falla et al. JOURNAL OF ALZHEIMERS DISEASE
- Abnormal Hyperphosphorylation of Tau: Sites, Regulation, and Molecular Mechanism of Neurofibrillary Degeneration
- (2018) Jian-Zhi Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- The amyloid cascade hypothesis: are we poised for success or failure?
- (2016) Eric Karran et al. JOURNAL OF NEUROCHEMISTRY
- Alzheimer's disease
- (2016) Philip Scheltens et al. LANCET
- A Mutation inDAOAModifies the Age of Onset inPSEN1E280A Alzheimer’s Disease
- (2016) Jorge I. Vélez et al. NEURAL PLASTICITY
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
- (2015) Celeste M. Karch et al. BIOLOGICAL PSYCHIATRY
- Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
- (2015) Melissa E. Murray et al. BRAIN
- Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease
- (2015) Maria Szaruga et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease
- (2015) M A Lalli et al. MOLECULAR PSYCHIATRY
- APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease
- (2015) J I Vélez et al. MOLECULAR PSYCHIATRY
- η-Secretase processing of APP inhibits neuronal activity in the hippocampus
- (2015) Michael Willem et al. NATURE
- The case for rejecting the amyloid cascade hypothesis
- (2015) Karl Herrup NATURE NEUROSCIENCE
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Bringing CLARITY to the human brain: visualization of Lewy pathology in three dimensions
- (2015) A. K. L. Liu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease
- (2015) Yakeel T. Quiroz et al. JAMA Neurology
- Pathways to Alzheimer's disease
- (2014) J. Hardy et al. JOURNAL OF INTERNAL MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis
- (2014) D. C. Ryman et al. NEUROLOGY
- The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
- (2014) Tara L. Spires-Jones et al. NEURON
- NetworkAnalyst - integrative approaches for protein–protein interaction network analysis and visual exploration
- (2014) Jianguo Xia et al. NUCLEIC ACIDS RESEARCH
- Meta-analysis of Ubiquilin1 gene polymorphism and Alzheimer’s disease risk
- (2014) Yingying Jia MEDICAL SCIENCE MONITOR
- Proteasome inhibition induces stress kinase dependent transport deficits — Implications for Alzheimer's disease
- (2013) Lotta Agholme et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Animal Models of Alzheimer Disease
- (2013) F. M. LaFerla et al. Cold Spring Harbor Perspectives in Medicine
- The Synaptic Accumulation of Hyperphosphorylated Tau Oligomers in Alzheimer Disease Is Associated With Dysfunction of the Ubiquitin-Proteasome System
- (2012) Hwan-Ching Tai et al. AMERICAN JOURNAL OF PATHOLOGY
- The mechanism of γ-Secretase dysfunction in familial Alzheimer disease
- (2012) Lucía Chávez-Gutiérrez et al. EMBO JOURNAL
- Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease
- (2012) Nobuto Kakuda et al. EMBO Molecular Medicine
- Identification of oligomers at early stages of tau aggregation in Alzheimer's disease
- (2012) Cristian A. Lasagna-Reeves et al. FASEB JOURNAL
- Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers
- (2012) Matthew A. Lalli et al. HUMAN MUTATION
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study
- (2012) Adam S Fleisher et al. LANCET NEUROLOGY
- Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease
- (2012) J I Vélez et al. MOLECULAR PSYCHIATRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Toward a multifactorial model of Alzheimer disease
- (2012) Martha Storandt et al. NEUROBIOLOGY OF AGING
- InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation
- (2012) Karin Breuer et al. NUCLEIC ACIDS RESEARCH
- Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
- (2011) Bradley T. Hyman ARCHIVES OF NEUROLOGY
- Structural Basis for Increased Toxicity of Pathological Aβ42:Aβ40Ratios in Alzheimer Disease
- (2011) Kris Pauwels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study
- (2011) Natalia Acosta-Baena et al. LANCET NEUROLOGY
- High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation
- (2010) David O Azorsa et al. BMC GENOMICS
- Deposition of Hyperphosphorylated Tau in Cerebellum of PS1 E280A Alzheimer's Disease
- (2010) Diego Sepulveda-Falla et al. BRAIN PATHOLOGY
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variations in the neuropathology of familial Alzheimer’s disease
- (2009) Claire Shepherd et al. ACTA NEUROPATHOLOGICA
- Mechanisms of tau-induced neurodegeneration
- (2009) Khalid Iqbal et al. ACTA NEUROPATHOLOGICA
- Presenilins are required for maintenance of neural stem cells in the developing brain
- (2008) Woo-Young Kim et al. Molecular Neurodegeneration
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started